As of 2025-12-26, the Relative Valuation of Precigen Inc (PGEN) is (14.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.19 USD, the upside of Precigen Inc based on Relative Valuation is -434.3%.
The range of the Relative Valuation is (12.70) - (12.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.0x - 25.7x | 21.8x |
| Forward P/E multiples | 18.2x - 18.4x | 18.3x |
| Fair Price | (12.70) - (12.84) | (14.01) |
| Upside | -403.1% - -406.4% | -434.3% |
| Date | P/E |
| 2025-12-24 | -6.01 |
| 2025-12-23 | -5.83 |
| 2025-12-22 | -6.28 |
| 2025-12-19 | -6.19 |
| 2025-12-18 | -5.98 |
| 2025-12-17 | -5.70 |
| 2025-12-16 | -5.55 |
| 2025-12-15 | -5.46 |
| 2025-12-12 | -5.29 |
| 2025-12-11 | -5.19 |
| 2025-12-10 | -5.03 |
| 2025-12-09 | -5.03 |
| 2025-12-08 | -5.29 |
| 2025-12-05 | -5.16 |
| 2025-12-04 | -5.37 |
| 2025-12-03 | -5.12 |
| 2025-12-02 | -4.99 |
| 2025-12-01 | -5.17 |
| 2025-11-28 | -5.49 |
| 2025-11-26 | -5.36 |
| 2025-11-25 | -5.26 |
| 2025-11-24 | -5.48 |
| 2025-11-21 | -5.56 |
| 2025-11-20 | -5.59 |
| 2025-11-19 | -6.05 |
| 2025-11-18 | -6.95 |
| 2025-11-17 | -7.02 |
| 2025-11-14 | -6.95 |
| 2025-11-13 | -5.53 |
| 2025-11-12 | -5.76 |
| 2025-11-11 | -5.68 |
| 2025-11-10 | -5.73 |
| 2025-11-07 | -5.59 |
| 2025-11-06 | -5.62 |
| 2025-11-05 | -5.72 |
| 2025-11-04 | -5.56 |
| 2025-11-03 | -5.96 |
| 2025-10-31 | -5.93 |
| 2025-10-30 | -5.80 |
| 2025-10-29 | -5.75 |
| 2025-10-28 | -5.82 |
| 2025-10-27 | -6.16 |
| 2025-10-24 | -6.21 |
| 2025-10-23 | -6.09 |
| 2025-10-22 | -5.60 |
| 2025-10-21 | -5.85 |
| 2025-10-20 | -5.65 |
| 2025-10-17 | -5.73 |
| 2025-10-16 | -5.00 |
| 2025-10-15 | -5.06 |